X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (45894) 45894
Book Review (8509) 8509
Publication (4882) 4882
Book Chapter (427) 427
Book / eBook (150) 150
Conference Proceeding (130) 130
Dissertation (58) 58
Newsletter (26) 26
Newspaper Article (19) 19
Reference (17) 17
Web Resource (9) 9
Data Set (7) 7
Magazine Article (4) 4
Government Document (2) 2
Presentation (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (41480) 41480
humans (27724) 27724
animals (23744) 23744
mice (11232) 11232
signal transduction (10444) 10444
phosphorylation (10032) 10032
male (9104) 9104
female (8997) 8997
cell biology (8814) 8814
biochemistry & molecular biology (8564) 8564
oncology (7634) 7634
expression (6537) 6537
proteins (6369) 6369
tyrosine (6005) 6005
activation (5874) 5874
cancer (5548) 5548
research (5473) 5473
kinases (5442) 5442
rats (5281) 5281
immunology (5178) 5178
protein-tyrosine kinases - metabolism (4701) 4701
mutation (4693) 4693
receptor protein-tyrosine kinases - genetics (4638) 4638
receptor (4567) 4567
gene expression (4499) 4499
cells, cultured (4336) 4336
analysis (4331) 4331
receptor protein-tyrosine kinases - metabolism (4165) 4165
molecular sequence data (4051) 4051
cell line (3959) 3959
protein-tyrosine kinase (3801) 3801
multidisciplinary sciences (3786) 3786
cell line, tumor (3650) 3650
middle aged (3630) 3630
article (3610) 3610
apoptosis (3589) 3589
neurosciences (3581) 3581
physiological aspects (3580) 3580
adult (3576) 3576
genetic aspects (3539) 3539
receptors (3499) 3499
cells (3417) 3417
amino acid sequence (3318) 3318
tyrosine kinase (3197) 3197
research article (3066) 3066
aged (2763) 2763
immunohistochemistry (2737) 2737
signal transduction - physiology (2669) 2669
signal transduction - drug effects (2662) 2662
medicine (2612) 2612
protein (2587) 2587
tumors (2570) 2570
growth-factor receptor (2553) 2553
abridged index medicus (2507) 2507
signal-transduction (2470) 2470
ligands (2436) 2436
genetics & heredity (2386) 2386
health aspects (2367) 2367
rodents (2361) 2361
pharmacology & pharmacy (2329) 2329
gene (2292) 2292
genes (2287) 2287
proto-oncogene proteins - genetics (2280) 2280
hematology (2253) 2253
endocrinology & metabolism (2249) 2249
base sequence (2244) 2244
biology (2215) 2215
protein binding (2176) 2176
mice, inbred c57bl (2156) 2156
gene-expression (2153) 2153
physiology (2137) 2137
epidermal growth factor (2131) 2131
in-vivo (2115) 2115
blotting, western (2091) 2091
protein-tyrosine kinases - antagonists & inhibitors (2088) 2088
tumor cells, cultured (2066) 2066
protein-tyrosine kinases - genetics (2063) 2063
science (2051) 2051
cell proliferation (2049) 2049
transfection (1986) 1986
tyrosine phosphorylation (1906) 1906
enzyme inhibitors - pharmacology (1905) 1905
identification (1856) 1856
care and treatment (1842) 1842
tyrosine - metabolism (1813) 1813
proto-oncogene proteins - metabolism (1796) 1796
pathology (1753) 1753
mice, knockout (1744) 1744
medicine, research & experimental (1735) 1735
receptor, epidermal growth factor - metabolism (1723) 1723
metastasis (1717) 1717
inhibition (1712) 1712
receptor tyrosine kinase (1708) 1708
in-vitro (1707) 1707
angiogenesis (1688) 1688
growth (1683) 1683
biochemistry (1677) 1677
biophysics (1674) 1674
signaling (1665) 1665
enzyme activation (1654) 1654
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (102) 102
Online Resources - Online (15) 15
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
UofT at Mississauga - Stacks (9) 9
UTL at Downsview - May be requested (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
UofT at Scarborough - Stacks (4) 4
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46047) 46047
Chinese (96) 96
Japanese (57) 57
German (48) 48
French (42) 42
Spanish (26) 26
Russian (17) 17
Polish (6) 6
Hungarian (4) 4
Czech (3) 3
Dutch (2) 2
Italian (2) 2
Korean (2) 2
Portuguese (2) 2
Swedish (2) 2
Arabic (1) 1
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Serbian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 234 - 242
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1011 - 1019
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
RESISTANT | MEDICINE, GENERAL & INTERNAL | MODELS | ANTITUMOR-ACTIVITY | INHIBITOR ALECTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 2, pp. djt378 - djt378
Journal Article
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 142, Issue 4, pp. 1021 - 1031.e15
Background & Aims Cholangiocarcinoma is a heterogeneous disease with a poor outcome that accounts for 5%−10% of primary liver cancers. We characterized its... 
Gastroenterology and Hepatology | CCA | Gene Expression | Hepatic | Genetic Analysis | SURVIVAL | INTRAHEPATIC CHOLANGIOCARCINOMA | PHASE-II | RECEPTOR | EXPRESSION PROFILES | BREAST-CANCER | BILIARY CANCER | LUNG-CANCER | HEPATOCELLULAR-CARCINOMA | MUTATIONS | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Proto-Oncogene Proteins p21(ras) | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Tumor Microenvironment | Male | Bile Duct Neoplasms - enzymology | Time Factors | Bile Duct Neoplasms - genetics | Cholangiocarcinoma - enzymology | Precision Medicine | Genetic Predisposition to Disease | Risk Assessment | Risk Factors | ras Proteins - antagonists & inhibitors | Survival Rate | Blotting, Western | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Phenotype | Belgium | Cell Line, Tumor | Cholangiocarcinoma - genetics | Mutation | Quinazolines - pharmacology | Trastuzumab | Cluster Analysis | Protein-Tyrosine Kinases - antagonists & inhibitors | ras Proteins - genetics | Prognosis | United States | Laser Capture Microdissection | Molecular Targeted Therapy | Patient Selection | Protein-Tyrosine Kinases - genetics | Antibodies, Monoclonal, Humanized - pharmacology | Female | Antineoplastic Agents - pharmacology | Bile Duct Neoplasms - drug therapy | Proto-Oncogene Proteins - antagonists & inhibitors | Bile Ducts, Intrahepatic - pathology | Cholangiocarcinoma - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Gene Expression Profiling - methods | Proto-Oncogene Proteins - genetics | Chi-Square Distribution | Bile Ducts, Intrahepatic - enzymology | Cholangiocarcinoma - pathology | Cholangiocarcinoma - drug therapy | Proto-Oncogene Proteins B-raf - genetics | Bile Duct Neoplasms - mortality | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Bile Duct Neoplasms - pathology | Protein-Tyrosine Kinases - analysis | Queensland | Tyrosine | Genes | Amino acids | Transforming growth factors | Gene expression | Liver cancer | Epidermal growth factor | Analysis | Phenols | Genetic research | Genetic aspects | Health aspects | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, pp. e15640 - e15640
Journal Article